Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
18.98
-0.59 (-3.01%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pacira BioSciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -90.73 | 41.96 | 15.91 | 41.98 | 145.52 | -11.02 | Upgrade
|
| Depreciation & Amortization | 76.03 | 75.57 | 81 | 28.55 | 19.91 | 19.58 | Upgrade
|
| Other Amortization | 3.06 | 3.75 | 7.21 | 25.91 | 20.41 | 15.45 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.02 | 1.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 36.63 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 10 | - | -1.62 | 4.32 | Upgrade
|
| Stock-Based Compensation | 51.33 | 47.9 | 48.09 | 42.25 | 39.92 | 33.65 | Upgrade
|
| Other Operating Activities | 173.99 | 31.25 | -37.14 | 12.55 | -113.34 | 14.84 | Upgrade
|
| Change in Accounts Receivable | -3.7 | -7.16 | -2.08 | -10.43 | -5.52 | -8.52 | Upgrade
|
| Change in Inventory | -15.35 | -8.29 | 2.49 | -4.47 | -6.35 | -8.03 | Upgrade
|
| Change in Accounts Payable | 2.34 | 0.92 | 6.27 | -10.26 | -3.31 | -1.82 | Upgrade
|
| Change in Other Net Operating Assets | 6.87 | -31.24 | -23.11 | -0.35 | -18.61 | 11.06 | Upgrade
|
| Operating Cash Flow | 203.84 | 154.65 | 145.27 | 125.72 | 77.03 | 70.52 | Upgrade
|
| Operating Cash Flow Growth | 36.71% | 6.45% | 15.56% | 63.20% | 9.23% | 44.30% | Upgrade
|
| Capital Expenditures | -10.32 | -15.16 | -30.08 | -45.87 | -37.8 | -10.16 | Upgrade
|
| Cash Acquisitions | - | - | -32 | -424.04 | - | -117.69 | Upgrade
|
| Investment in Securities | -64.22 | 92.7 | -163.11 | 449.12 | -239.81 | -0.64 | Upgrade
|
| Investing Cash Flow | -74.53 | 77.54 | -225.19 | -20.79 | -277.61 | -128.49 | Upgrade
|
| Long-Term Debt Issued | - | 149.55 | - | 363.75 | 314.71 | - | Upgrade
|
| Total Debt Issued | 287.5 | 149.55 | - | 363.75 | 314.71 | - | Upgrade
|
| Long-Term Debt Repaid | - | -330.31 | -427.69 | - | -176.79 | -0.34 | Upgrade
|
| Net Debt Issued (Repaid) | 76.62 | -180.76 | -427.69 | 363.75 | 137.92 | -0.34 | Upgrade
|
| Issuance of Common Stock | 2.5 | 4.75 | 27.34 | 26.66 | 135.56 | 10.87 | Upgrade
|
| Repurchase of Common Stock | -25.52 | -0.11 | - | - | -33.09 | - | Upgrade
|
| Other Financing Activities | -36.06 | -6.91 | -1.18 | -9.71 | -18.08 | -6.86 | Upgrade
|
| Financing Cash Flow | 17.54 | -183.03 | -401.53 | 380.69 | 222.3 | 3.67 | Upgrade
|
| Net Cash Flow | 146.85 | 49.16 | -481.44 | 485.62 | 21.73 | -54.3 | Upgrade
|
| Free Cash Flow | 193.53 | 139.49 | 115.2 | 79.85 | 39.23 | 60.36 | Upgrade
|
| Free Cash Flow Growth | 48.58% | 21.09% | 44.27% | 103.54% | -35.01% | 75.69% | Upgrade
|
| Free Cash Flow Margin | 27.85% | 20.67% | 17.28% | 14.75% | 9.13% | 14.34% | Upgrade
|
| Free Cash Flow Per Share | 4.18 | 2.68 | 2.48 | 1.75 | 0.90 | 1.45 | Upgrade
|
| Cash Interest Paid | 12.9 | 27.64 | 33.3 | 7 | 7.21 | 8.2 | Upgrade
|
| Cash Income Tax Paid | 11.87 | 4.37 | 7.4 | 3.22 | 2.42 | 0.86 | Upgrade
|
| Levered Free Cash Flow | 169.56 | 107.15 | 92 | 49.79 | 38.75 | 86.39 | Upgrade
|
| Unlevered Free Cash Flow | 176.05 | 116.09 | 109.78 | 43.72 | 34.39 | 85.71 | Upgrade
|
| Change in Net Working Capital | 4.74 | 46.79 | 33.57 | 37.41 | 19.84 | -20.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.